Cybrdi Inc (CYDI) 0.0352 $CYDI
CBS Outdoor Americas Climbs on First Day of Trading; FDA Advisory Panel Recommends Approval of Exact Sciences Corporation's Cologuard
ACCESSWIRE - Sun Mar 30, 11:16PM CDT
CBS Outdoor Americas Inc. (NYSE: CBSO) - For an in-depth report on CBS Outdoor Americas Inc. follow: www.BullTrends.com/stockquote/CBSO
CBSO: 30.98 (-0.10), EXAS: 23.00 (-0.11)
Global Biochips Market 2012-2016: Major Challenge for Market is High Cost Incurred in the Implementation of Biochips
M2 - Thu Mar 20, 11:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcvpcl/global_biochips) has announced the addition of the "Global Biochips Market 2012-2016" report to their offering. The analysts forecast the Global Biochips market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. Key vendors dominating this space include Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd. and Agilent Technologies Inc. Other vendors mentioned in the report are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc. Commenting on the report, an analyst from the Hardware team said: ''Over the years, numerous drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend for the Global Biochips market.'' According to the report, one of the major drivers is the growing need for high speed diagnosis from patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, therefore, enhancing their operating speed to a great extent. For more information visit http://www.researchandmarkets.com/research/bc...l_biochips About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
FLDM: 29.99 (+0.11), ILMN: 180.50 (-4.50), AFFX: 9.71 (+0.02)
The Global Biochips Market to Grow At A CAGR Of 19.1 Percent over the Period 2012-2016
M2 - Fri May 24, 11:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wcd9f3/global_biochips) has announced the addition of the "Global Biochips Market 2012-2016" report to their offering. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. Key vendors dominating this space include Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd. and Agilent Technologies Inc. Other vendors mentioned in the report are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc. Commenting on the report, an analyst from TechNavio's Hardware team said: ''Over the years, numero
FLDM: 29.99 (+0.11), ILMN: 180.50 (-4.50), AFFX: 9.71 (+0.02)
CBS Outdoor Americas Climbs on First Day of Trading; FDA Advisory Panel Recommends Approval of Exact Sciences Corporation's Cologuard
ACCESSWIRE - Sun Mar 30, 11:16PM CDT
CBS Outdoor Americas Inc. (NYSE: CBSO) - For an in-depth report on CBS Outdoor Americas Inc. follow: www.BullTrends.com/stockquote/CBSO
CBSO: 30.98 (-0.10), EXAS: 23.00 (-0.11)
Global Biochips Market 2012-2016: Major Challenge for Market is High Cost Incurred in the Implementation of Biochips
M2 - Thu Mar 20, 11:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcvpcl/global_biochips) has announced the addition of the "Global Biochips Market 2012-2016" report to their offering. The analysts forecast the Global Biochips market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. Key vendors dominating this space include Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd. and Agilent Technologies Inc. Other vendors mentioned in the report are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc. Commenting on the report, an analyst from the Hardware team said: ''Over the years, numerous drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend for the Global Biochips market.'' According to the report, one of the major drivers is the growing need for high speed diagnosis from patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, therefore, enhancing their operating speed to a great extent. For more information visit http://www.researchandmarkets.com/research/bc...l_biochips About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
FLDM: 29.99 (+0.11), ILMN: 180.50 (-4.50), AFFX: 9.71 (+0.02)
The Global Biochips Market to Grow At A CAGR Of 19.1 Percent over the Period 2012-2016
M2 - Fri May 24, 11:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wcd9f3/global_biochips) has announced the addition of the "Global Biochips Market 2012-2016" report to their offering. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. Key vendors dominating this space include Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd. and Agilent Technologies Inc. Other vendors mentioned in the report are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc. Commenting on the report, an analyst from TechNavio's Hardware team said: ''Over the years, numero
FLDM: 29.99 (+0.11), ILMN: 180.50 (-4.50), AFFX: 9.71 (+0.02)
